phage_display

Antibody production relies on diverse technologies. Biointron reviews methods from hybridoma to recombinant platforms that power research and drug development.

Phage display technology revolutionizes antibody discovery. Biointron applies this platform to identify high-affinity binders and accelerate therapeutic innovation.

From hybridomas to recombinant platforms, antibody production has evolved. Biointron reveals ten insights into methods that ensure reliable supply and scientific progress.

Phage display technology accelerates antibody discovery and engineering. Biointron applies this powerful tool to identify high-affinity binders and therapeutic candidates.